Literature DB >> 21142700

Sequential delivery of basic fibroblast growth factor and platelet-derived growth factor for angiogenesis.

Jillian E Tengood1, Ryan Ridenour, Ross Brodsky, Alan J Russell, Steven R Little.   

Abstract

An externally regulated delivery model that permits temporal separation of multiple angiogenic factors was used for the delivery of basic fibroblast growth factor (bFGF) and platelet-derived growth factor (PDGF). While bFGF plays a significant role in the sprouting of new capillaries, PDGF plays a role in the recruitment of mural cells, which stabilize neovessels. However, these two factors have been shown to inhibit each other, when presented together. Using the externally regulated model, sequential delivery of bFGF and PDGF led to not only increased endothelial cell migration, but also endothelial cell and vascular pericyte colocalization. More importantly, this delivery strategy was able to induce red blood cell-filled neovessels, suggesting integration of angiogenesis with the existing vasculature.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21142700      PMCID: PMC3120092          DOI: 10.1089/ten.TEA.2010.0551

Source DB:  PubMed          Journal:  Tissue Eng Part A        ISSN: 1937-3341            Impact factor:   3.845


  54 in total

1.  The immunological synapse: a molecular machine controlling T cell activation.

Authors:  A Grakoui; S K Bromley; C Sumen; M M Davis; A S Shaw; P M Allen; M L Dustin
Journal:  Science       Date:  1999-07-09       Impact factor: 47.728

2.  Effects of angiogenesis inhibitors on multistage carcinogenesis in mice.

Authors:  G Bergers; K Javaherian; K M Lo; J Folkman; D Hanahan
Journal:  Science       Date:  1999-04-30       Impact factor: 47.728

3.  Blood vessel maturation: vascular development comes of age.

Authors:  D C Darland; P A D'Amore
Journal:  J Clin Invest       Date:  1999-01       Impact factor: 14.808

Review 4.  Platelet-derived growth factor (PDGF): actions and mechanisms in vascular smooth muscle.

Authors:  A D Hughes; G F Clunn; J Refson; C Demoliou-Mason
Journal:  Gen Pharmacol       Date:  1996-10

5.  Recombinant human bone morphogenetic protein induces bone formation.

Authors:  E A Wang; V Rosen; J S D'Alessandro; M Bauduy; P Cordes; T Harada; D I Israel; R M Hewick; K M Kerns; P LaPan
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

Review 6.  The bone morphogenetic protein family and osteogenesis.

Authors:  J M Wozney
Journal:  Mol Reprod Dev       Date:  1992-06       Impact factor: 2.609

7.  Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro.

Authors:  T K Sampath; J C Maliakal; P V Hauschka; W K Jones; H Sasak; R F Tucker; K H White; J E Coughlin; M M Tucker; R H Pang
Journal:  J Biol Chem       Date:  1992-10-05       Impact factor: 5.157

8.  Basic fibroblast growth factor modulates the mitogenic potency of the platelet-derived growth factor (PDGF) isoforms by specific upregulation of the PDGF alpha receptor in vascular smooth muscle cells.

Authors:  C Schöllmann; R Grugel; D Tatje; J Hoppe; J Folkman; D Marmé; H A Weich
Journal:  J Biol Chem       Date:  1992-09-05       Impact factor: 5.157

9.  Heparin structure and interactions with basic fibroblast growth factor.

Authors:  S Faham; R E Hileman; J R Fromm; R J Linhardt; D C Rees
Journal:  Science       Date:  1996-02-23       Impact factor: 47.728

10.  Basic fibroblast growth factor: production and growth stimulation in cultured adrenal cortex cells.

Authors:  L Schweigerer; G Neufeld; J Friedman; J A Abraham; J C Fiddes; D Gospodarowicz
Journal:  Endocrinology       Date:  1987-02       Impact factor: 4.736

View more
  30 in total

1.  Ultrastructural immunolocalization of basic fibroblast growth factor in endothelial cells: morphologic evidence for unconventional secretion of a novel protein.

Authors:  Ranan Gulhan Aktas; Robert J Kayton
Journal:  J Mol Histol       Date:  2011-08-10       Impact factor: 2.611

Review 2.  Role of platelet-rich plasma in ischemic heart disease: An update on the latest evidence.

Authors:  Eleftherios Spartalis; Periklis Tomos; Demetrios Moris; Antonios Athanasiou; Charalampos Markakis; Michael D Spartalis; Theodore Troupis; Dimitrios Dimitroulis; Despina Perrea
Journal:  World J Cardiol       Date:  2015-10-26

3.  Sequential delivery of angiogenic growth factors improves revascularization and heart function after myocardial infarction.

Authors:  Hassan K Awada; Noah R Johnson; Yadong Wang
Journal:  J Control Release       Date:  2015-03-31       Impact factor: 9.776

Review 4.  Controlled release strategies for bone, cartilage, and osteochondral engineering--Part II: challenges on the evolution from single to multiple bioactive factor delivery.

Authors:  Vítor E Santo; Manuela E Gomes; João F Mano; Rui L Reis
Journal:  Tissue Eng Part B Rev       Date:  2013-01-30       Impact factor: 6.389

Review 5.  Towards comprehensive cardiac repair and regeneration after myocardial infarction: Aspects to consider and proteins to deliver.

Authors:  Hassan K Awada; Mintai P Hwang; Yadong Wang
Journal:  Biomaterials       Date:  2015-12-29       Impact factor: 12.479

6.  The incorporation of bFGF mediated by heparin into PCL/gelatin composite fiber meshes for guided bone regeneration.

Authors:  Ji-hye Lee; Young Jun Lee; Hyeong-jin Cho; Dong Wan Kim; Heungsoo Shin
Journal:  Drug Deliv Transl Res       Date:  2015-04       Impact factor: 4.617

7.  Tunable protein release from acetalated dextran microparticles: a platform for delivery of protein therapeutics to the heart post-MI.

Authors:  Sophia Suarez; Gregory N Grover; Rebecca L Braden; Karen L Christman; Adah Almutairi
Journal:  Biomacromolecules       Date:  2013-10-16       Impact factor: 6.988

8.  Ordered and kinetically discrete sequential protein release from biodegradable thin films.

Authors:  Bryan B Hsu; Kelsey S Jamieson; Samantha R Hagerman; Eggehard Holler; Julia Y Ljubimova; Paula T Hammond
Journal:  Angew Chem Int Ed Engl       Date:  2014-06-18       Impact factor: 15.336

Review 9.  Sphingosine 1-phosphate (S1P) signalling: Role in bone biology and potential therapeutic target for bone repair.

Authors:  Ziad Sartawi; Ernestina Schipani; Katie B Ryan; Christian Waeber
Journal:  Pharmacol Res       Date:  2017-09-22       Impact factor: 7.658

Review 10.  Controlled drug release for tissue engineering.

Authors:  Kunal J Rambhia; Peter X Ma
Journal:  J Control Release       Date:  2015-08-29       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.